Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Post by 1stocksRus1on Sep 13, 2011 3:49pm
458 Views
Post# 19038138

quick calculation based on today's invertivew

quick calculation based on today's invertivewHello allI did a quick calculation of potential market cap (MC) just based on the dermatologist numbers that TB mentioned in the interview today, currently we have a market cap about 49 million.even if only 10% of dermatologists in europe buy the unit (for 60k a pop) that is revenue of 126 million. putting our potential MC at $2.10 per share.@ 25%, 315 million, @ 50% 630 million, @ 75% 945 million, and all 100% dermatologists buying the unit would equate to 1.26 billion in sales. corresponding SP, 25% = $5.25, 50% = $10.50, 75% $15.75, 100% = $21.00mind you i haven't factored in net profit per unit (since we don't know), lets be ultra ridiculous and say it costs 30k per unit to produce, even at 30k net profit per unit , which I KNOW is NOT true since they were willing to sell the unit for 30k initially, we would still get a SP 1.05 at the 10% mark! And remember, I haven't even factored in the recurring sales for the disposable tips!And this is only for Europe.. I wonder how many dermatologists are in Australia?And don't forget the General Practitioners... if they buy as well, this can only go up from here.Didn't TB mentioned that in Germany it costs 150 euro per visit? that means it would require 400 patient visit to pay the unit off, which would be in no time.Let's all wish for those approvals!If I made a calculation error, please let me know,any inputs would be appreciated.all info, just my ramblings, do your DD!GLTA
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse